John Craighead | Vice President-Investor Relations and Corporate Communications |
Pascal Touchon | President and Chief Executive Officer |
AJ Joshi | Chief Medical Officer |
Joe Newell | Chief Operations Officer |
Phil Nadeau | Cowen & Company |
John Newman | Canaccord |
Matt Phipps | William Blair |
Salim Syed | Mizuho Securities |
Benjamin Burnett | Stifel |
Good morning, ladies and gentlemen, and welcome to the Atara Biotherapeutics Q4 and Full Year 2019 Financial Results Conference Call. At this time, all participants’ are in a listen-only mode. Later, we will conduct a question-and-answer session.
I would now like to turn the conference over to your host, Dr. John Craighead, Vice President of Investor Relations and Corporate Communications of Atara Biotherapeutics.